Mixing-tank model for predicting dissolution rate control or oral absorption.

A mixing-tank model is used to simulate GI absorption of nonionized drugs. The model is useful for predicting circumstances under which dissolution rate dominates membrane transport and transit rate, thus limiting the extent of absorption. The model is developed from mass balance considerations in which the nonsink dissolution term is a function of the remaining surface area and the concentration gradient across the boundary layer. Other dissolution parameters include initial particle radius, dose, diffusivity, density, and boundary-layer thickness. Readily calculable estimators for the general solution of the model are derived and their ranges of usefulness are discussed. Drug examples chosen for simulation are griseofulvin and digoxin. The model correctly predicts bioavailability as a function of particle size for both of these poorly soluble drugs.

[1]  H. Merkle,et al.  Quantitative, mechanistic and physiologically realistic approach to the biopharmaceutical design of oral drug delivery systems , 1983 .

[2]  E. Townley,et al.  Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data. , 1970, Journal of pharmaceutical sciences.

[3]  A. Rescigno,et al.  Drug and tracer kinetics , 1966 .

[4]  C. Rhodes,et al.  Particle size of commercial griseofulvin with reference to official standards. , 1967, Journal of pharmaceutical sciences.

[5]  R. G. Crounse,et al.  Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption. , 1961, The Journal of investigative dermatology.

[6]  J. Fordtran,et al.  Volume-Flow Relationship During the Transport of Fluid Through the Human Small Intestine , 1965 .

[7]  G. Amidon,et al.  Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.

[8]  S. Riegelman,et al.  Absorption characteristics of solid dispersed and micronized griseofulvin in man. , 1971, Journal of pharmaceutical sciences.

[9]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[10]  G. Amidon,et al.  Physicochemical model for dose-dependent drug absorption. , 1984, Journal of pharmaceutical sciences.

[11]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[12]  A. Zinsmeister,et al.  Relationship of motility to flow of contents in the human small intestine. , 1982, Gastroenterology.

[13]  D. Azarnoff,et al.  Absorption of orally given digoxin preparations. , 1972, JAMA.

[14]  M. Kraml,et al.  Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man. , 1962, Antibiotics & chemotherapy.

[15]  A. Florence,et al.  Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and oestradiol * , 1976, The Journal of pharmacy and pharmacology.

[16]  N. D. Parks The British Pharmacopeia. , 1901 .

[17]  K. J. Child,et al.  The effect of griseofulvin particle size on blood levels in man. , 1962, Antibiotics & chemotherapy.

[18]  S. Phillips,et al.  Passage of carbohydrate into the colon. Direct measurements in humans , 1983 .

[19]  R. Hatcher THE UNITED STATES PHARMACOPEIA. , 1908 .

[20]  A. Marzo,et al.  Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients. , 1979, Journal of pharmaceutical sciences.

[21]  J. Malagelada,et al.  Intestinal transit of solid and liquid components of a meal in health , 1984 .

[22]  S. Symchowicz,et al.  Correlation of dissolution rate and griseofulvin absorption in man. , 1967, Journal of pharmaceutical sciences.